Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients Treated for Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00167908
What this trial is testing

Study of Amifostine and IMRT for Protecting Salivary Glands in Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Washington University School of Medicine 27
Testing effectiveness (Phase 2)Study completedNCT00014508
What this trial is testing

Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Ended earlyNCT00853125
What this trial is testing

Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Rutgers, The State University of New Jersey 10
Not applicableStudy completedNCT04800991
What this trial is testing

NuGa (Nutrition for Gastric Cancer Patients)

Who this might be right for
Gastric Cancer
Seoul National University Hospital 40
Post-approval studies (Phase 4)Ended earlyNCT01266291
What this trial is testing

Sabril for Complex Partial Seizures in Adult Tolerability Study (TS) Patients

Who this might be right for
Complex Partial Seizures
University of Pennsylvania 1
Testing effectiveness (Phase 2)Ended earlyNCT00601848
What this trial is testing

Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the Pleura

Who this might be right for
Lung CancerMetastatic Cancer
Abramson Cancer Center at Penn Medicine 9
Very early researchLooking for participantsNCT07707648
What this trial is testing

Evaluation of the Feasibility and Safety of ENCER for Cancer Treatment-Related Fatigue in Patients Receiving Chemotherapy or Radiotherapy

Who this might be right for
Fatigue Related to Cancer Treatment
Beaura for Para Pharmaceutical Products Trading LLC 74
Not applicableStudy completedNCT01182155
What this trial is testing

Breath Analysis for Evaluation of Radiation Exposure in Lung Cancer Patients Treated With Radiation

Who this might be right for
Lung CancerNon-Small Cell Lung CancerSmall Cell Lung Cancer
Stanford University 20
Testing effectiveness (Phase 2)Looking for participantsNCT06423326
What this trial is testing

Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic Ductal AdenocarcinomaResectable Pancreatic AdenocarcinomaStage I Pancreatic Cancer AJCC v8+2 more
Emory University 36
Testing effectiveness (Phase 2)Ended earlyNCT00262925
What this trial is testing

Combination Chemotherapy and Alemtuzumab in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia

Who this might be right for
Recurrent Adult Acute Lymphoblastic Leukemia
National Cancer Institute (NCI) 12
Early research (Phase 1)Study completedNCT00652691
What this trial is testing

Topotecan, High-Dose Cyclophosphamide, Carboplatin, and an Autologous Peripheral Blood Cell Transplant in Treating Patients With Recurrent Ovarian Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPeritoneal Cavity Cancer
Mayo Clinic 48
Large-scale testing (Phase 3)Active Not RecruitingNCT03186898
What this trial is testing

Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer

Who this might be right for
Recurrent Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v7Unresectable Hepatocellular Carcinoma
NRG Oncology 115
Testing effectiveness (Phase 2)UnknownNCT03337087
What this trial is testing

Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer

Who this might be right for
Metastatic Biliary Tract CarcinomaMetastatic Colorectal CarcinomaMetastatic Gastroesophageal Junction Adenocarcinoma+6 more
Academic and Community Cancer Research United 18
Large-scale testing (Phase 3)UnknownNCT03709316
What this trial is testing

ZL-2306 (Niraparib) as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer

Who this might be right for
Ovarian Cancer
Zai Lab (Shanghai) Co., Ltd. 384
Testing effectiveness (Phase 2)Study completedNCT00612716
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Masonic Cancer Center, University of Minnesota 6
Large-scale testing (Phase 3)Study completedNCT00519285
What this trial is testing

Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer

Who this might be right for
Prostatic NeoplasmsNeoplasm Metastasis
Sanofi 1,224
Post-approval studies (Phase 4)UnknownNCT04864717
What this trial is testing

Doxycycline vs Isotretinoin for Acneiform Eruptions of TKI

Who this might be right for
Acneiform EruptionsCancer, Treatment-Related
Lady Davis Institute 98
Early research (Phase 1)Looking for participantsNCT04881240
What this trial is testing

Study of CD19 Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseAcute Lymphoblastic Leukemia, RefractoryPediatric ALL
St. Jude Children's Research Hospital 60
Not applicableNo Longer AvailableNCT05503550
What this trial is testing

Pre-Approval Access Single Patient Request for Talquetamab in Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Janssen Research & Development, LLC
Testing effectiveness (Phase 2)Looking for participantsNCT06712680
What this trial is testing

A Phase I/II Study of HYP-6589 Monotherapy in Treating Advanced Solid Tumors and in Combination With Tyrosine Kinase Inhibitors in Treating Patients With Advanced NSCLC Positive for Driver Genes

Who this might be right for
Solid Tumor
Sichuan Huiyu Pharmaceutical Co., Ltd 115
Next Page